about
Multilayered mechanism of CD4 downregulation by HIV-1 Vpu involving distinct ER retention and ERAD targeting stepsActivation of Wnt5A signaling is required for CXC chemokine ligand 12-mediated T-cell migrationPotent antiviral synergy between monoclonal antibody and small-molecule CCR5 inhibitors of human immunodeficiency virus type 1Apoptotic killing of HIV-1-infected macrophages is subverted by the viral envelope glycoproteinTwo HIV-1 variants resistant to small molecule CCR5 inhibitors differ in how they use CCR5 for entryCCR5 gene disruption via lentiviral vectors expressing Cas9 and single guided RNA renders cells resistant to HIV-1 infectionSoluble Envelope Glycoprotein Trimers from a CD4-Independent HIV-1 Elicit Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies in Guinea PigsHIV/AIDS epidemiology, pathogenesis, prevention, and treatmentModulation of HIV-1-host interaction: role of the Vpu accessory proteinInduction of a Tier-1-like Phenotype in Diverse Tier-2 Isolates by Agents that Guide HIV-1 Env to Perturbation-sensitive, Non-native States.Human domain antibodies to conserved sterically restricted regions on gp120 as exceptionally potent cross-reactive HIV-1 neutralizers.Inhibition of HIV-1 entry by extracts derived from traditional Chinese medicinal herbal plantsProgress towards recombinant anti-infective antibodies.A genotypic HIV-1 proviral DNA coreceptor tropism assay: characterization in viremic subjects.Contribution of intrinsic reactivity of the HIV-1 envelope glycoproteins to CD4-independent infection and global inhibitor sensitivity.Macrophage migration inhibitory factor is secreted by rhabdomyosarcoma cells, modulates tumor metastasis by binding to CXCR4 and CXCR7 receptors and inhibits recruitment of cancer-associated fibroblastsAll-atom models of the membrane-spanning domain of HIV-1 gp41 from metadynamics.A genotypic test for HIV-1 tropism combining Sanger sequencing with ultradeep sequencing predicts virologic response in treatment-experienced patientsHIV takes double hit before entryNef neutralizes the ability of exosomes from CD4+ T cells to act as decoys during HIV-1 infection.Inhibition of HIV-1 infection by a unique short hairpin RNA to chemokine receptor 5 delivered into macrophages through hematopoietic progenitor cell transductionPersistent resistance to HIV-1 infection in CD4 T cells from exposed uninfected Vietnamese individuals is mediated by entry and post-entry blocks.Molecular aspects of HTLV-1 entry: functional domains of the HTLV-1 surface subunit (SU) and their relationships to the entry receptors.Evolution and recombination of genes encoding HIV-1 drug resistance and tropism during antiretroviral therapyDetermination of HIV-1 coreceptor tropism using proviral DNA in women before and after viral suppressionTransmembrane domain determinants of CD4 Downregulation by HIV-1 Vpu.Host factors influencing susceptibility to HIV infection and AIDS progression.Evolution of coreceptor utilization to escape CCR5 antagonist therapy.Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1Structure-Based Design of a Small Molecule CD4-Antagonist with Broad Spectrum Anti-HIV-1 Activity.Structure, function and physiological consequences of virally encoded chemokine seven transmembrane receptorsRole of the membrane-spanning domain of human immunodeficiency virus type 1 envelope glycoprotein in cell-cell fusion and virus infectionStable gene transfer of CCR5 and CXCR4 siRNAs by sleeping beauty transposon system to confer HIV-1 resistance.A basic patch on alpha-adaptin is required for binding of human immunodeficiency virus type 1 Nef and cooperative assembly of a CD4-Nef-AP-2 complex.Human immunodeficiency virus type 1 Nef protein targets CD4 to the multivesicular body pathway.Truncation of the membrane-spanning domain of human immunodeficiency virus type 1 envelope glycoprotein defines elements required for fusion, incorporation, and infectivityComparison of genotypic and phenotypic HIV type 1 tropism assay: results from the screening samples of Cenicriviroc Study 202, a randomized phase II trial in treatment-naive subjects.The role of stromal-derived factor-1--CXCR7 axis in development and cancer.Antibody epitopes on g protein-coupled receptors mapped with genetically encoded photoactivatable cross-linkers.Mechanisms underlying HIV-1 Vpu-mediated viral egress.
P2860
Q21131559-2C025F23-06FC-4C68-9DE8-B846DCDA5DACQ24337756-0E54839B-2E9B-49C9-85E5-8A9925CE5FC6Q24673555-7D353633-6ED8-4FB6-8787-E96704C226F5Q28472613-78661ADA-FBDB-494E-99E6-8C0070F3EF3EQ28475912-EF35E4F2-0D72-4C5A-971B-0D4AFE21A87AQ28542878-1FD45A1F-730E-4E3E-8594-4932C14ED1D9Q30278897-BC4121D3-D1CB-46A0-9608-041F50F4B71AQ30356074-FF056E61-F9D6-476C-AE3D-875E833DF8B5Q30397761-24E12D6F-ED7B-496C-BD46-E71B858AE2BDQ30401836-1F24EA76-C682-45FD-B10D-6BBE85677249Q33380012-E9FF7C60-2ECC-4095-A343-453A7CA58848Q33490833-86E924EA-3D15-4060-926A-9E9A7D3F8DE0Q33568256-2F6630C8-CA4E-4B97-B347-4AEE535E9A51Q33712327-838019F1-1DDF-43A9-B000-70E2EA2C73DBQ33951963-D886B9E5-16E8-43E8-83C0-DEB0D6C799D6Q34280104-FD68D571-9E12-4BFC-ACE7-49213066AF29Q34306895-65F8ADF3-2A4C-45CF-853A-24E0878E2771Q34431102-F1B0A39C-4602-4C21-9EE7-F1ADB59B789AQ34502641-B655FC11-C2CE-4B48-986A-3AEE788BC270Q34572074-78658252-2237-45E5-BB08-6DD1348D35F8Q35122039-FD9F2E6F-5EF5-461B-A819-ADB71FE8A900Q35131130-A6DC5012-3FB1-4B74-90F1-23DF46A8A3EFQ35261405-A3C39ED1-E1E7-4C21-A5B4-80D8B488DBC6Q35264750-8FFF7F3B-643A-4733-A80D-373A321172B3Q35491675-B0C0DED6-17F1-48BC-BB31-97F8214E84C4Q35665886-358169F1-4527-4CEC-8A20-8DE9D6521950Q35995936-90BF7C4A-06F4-479E-8562-3767E66577DEQ36003168-74B7DB07-F4A4-4ECE-ACDC-06E6F645BCDEQ36229284-A7C56A08-C50E-4A1E-A99B-3860D4E1FF35Q36364955-3A62D63B-9E30-4E1D-B22F-11ACB105A061Q36497002-5E065971-CFAE-4227-A32E-5AFB5BFEF9AFQ36673306-2EC15322-A976-4F4E-8F24-6A93B2E63589Q36870325-83415BC2-5395-4171-B953-2D3D7BA12A95Q37110624-C785FA85-F368-4B22-8F24-5D1D241536FAQ37232786-112B1CAC-4529-43F8-8453-BC8E57184B52Q37410656-8A711ABF-128F-4C73-8882-04D36F030563Q37547823-C385B57E-8F63-4910-8A29-252B6646DA08Q37616298-90D0A0AF-0457-4A11-B4E2-5650F01BA2A1Q37701720-DF990E41-93C3-439E-A8DF-CDBF76C0B23EQ38211428-AE80DB8D-A7E6-4453-B602-DF5B6A13E801
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
HIV-1 coreceptors and their inhibitors.
@ast
HIV-1 coreceptors and their inhibitors.
@en
HIV-1 coreceptors and their inhibitors.
@nl
type
label
HIV-1 coreceptors and their inhibitors.
@ast
HIV-1 coreceptors and their inhibitors.
@en
HIV-1 coreceptors and their inhibitors.
@nl
prefLabel
HIV-1 coreceptors and their inhibitors.
@ast
HIV-1 coreceptors and their inhibitors.
@en
HIV-1 coreceptors and their inhibitors.
@nl
P1476
HIV-1 coreceptors and their inhibitors.
@en
P304
P577
2006-01-01T00:00:00Z